Skip to main content

Day: August 27, 2020

Cerner Teams With Amazon to Help Consumers Improve Their Health and Wellness

Integration Empowers Consumers to Measure and Share Important Data With Health Care TeamsSharp Healthcare First Health System to Implement HaloKANSAS CITY, Mo., Aug. 27, 2020 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN), a global health care technology company, announced today a new collaboration with Amazon (Nasdaq: AMZN) that allows consumers to easily connect vital health and well-being information with their broader health care teams. The Amazon Halo, a new service dedicated to helping customers improve health and wellness, can connect to Cerner’s technology where individuals can opt-in to share activity, sleep, body fat percentage and other important wellness data from the comfort of their home. Historically this type of data has been siloed or difficult to obtain. Wearable technology, such as the Amazon Halo, can help...

Continue reading

Notification Pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act: Joensuun Kauppa ja Kone oy

Dovre Group Plc                  Major shareholder announcements                   August 27, 2020 at 5:00 pmNOTIFICATION PURSUANT TO CHAPTER 9, SECTION 5 OF THE FINNISH SECURITIES MARKETS ACT: JOENSUUN KAUPPA JA KONE OYDovre Group Plc has received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from Kyösti Kakkonen. According to the notification, the ownership of Joensuun Kauppa ja Kone Oy to shares and voting rights in Dovre Group Plc has increased above 10%. Joensuun Kauppa ja Kone Oy is an entity controlled by Kyösti Kakkonen.Notified details of the resulting situation on the date on which the threshold was crossed or reached:According to the notification, the total number of shares and voting rights in Dovre Group Plc held by Joensuun Kauppa ja Kone Oy is 10,315,917 pcs (10.12%) and K22 Finance...

Continue reading

Arvopaperimarkkinalain 9 luvun 5 §:N mukainen ilmoitus: Joensuun Kauppa ja Kone Oy

Dovre Group Oyj                  Suurimmat osakkeenomistajat                   27.08.2020 klo 17.00ARVOPAPERIMARKKINALAIN 9 LUVUN 5 §:N MUKAINEN ILMOITUS: JOENSUUN KAUPPA JA KONE OYDovre Group Oyj on vastaanottanut Arvopaperimarkkinalain 9 luvun 5 §:n mukaisen ilmoituksen Kyösti Kakkoselta. Liputusilmoituksen mukaan Kyösti Kakkosen määräysvaltayhtiö Joensuun kauppa ja Kone Oy:n omistusosuus Dovre Group Oyj:n osakkeista ja äänistä on ylittänyt 10 prosenttia.Tiedot omistus- ja ääniosuudesta liputusrajan saavuttamisen tai rikkoutumisen jälkeen:Liputusilmoituksen mukaan Kyösti Kakkosen määräysvaltayhtiö Joensuun Kauppa ja Kone Oy omistaa 10 315 917 kappaletta (10,12%) ja määräysvaltayhtiö K22 Finance Oy 2 000 000 kappaletta (1,96%) Dovre Group Oyj:n osakkeista ja äänistä.Dovre Group Oyj:n kaupparekisteriin merkitty osakemäärä on 102 956 494...

Continue reading

Announcement from Systemair AB (publ) Annual General Meeting 2020

Press Release, 27 August 2020Systemair (NASDAQ OMX Stockholm: SYSR) held its Annual General Meeting on August 26, 2020 in the Systemair Expo in Skinnskatteberg, Sweden. At the AGM, 68 shareholders entitled to vote were present representing 81.66% of the total number of votes and shares. The Meeting voted in favour of the Board’s proposal in all suggestions. The most important decisions main content was:DividendThe Annual General Meeting decided that no dividend be paid for the financial year 2019/20 and that at the disposal of the Annual General Meeting’s standing funds of SEK 1,705,759,197 be balanced in a new account.The BoardThe Annual General Meeting decided that Carina Andersson, Gerald Engström, Patrik Nolåker, Svein Nilsen and Gunilla Spongh should be re-elected. Gerald Engström was elected as Chairman of the Board of Directors.Resolution...

Continue reading

Kommuniké från Systemair AB (publ) årsstämma 2020

Pressmeddelande 27 augusti 2020Systemair (NASDAQ OMX Stockholm: SYSR) höll sin årsstämma den 26 augusti 2020 i Systemair Expo i Skinnskatteberg. På stämman var 68 röstberättigande aktieägare närvarande som representerade 81,66% av det totala antalet röster och aktier. Stämman beslutade i enlighet med styrelsens förslag i samtliga föreslagna ärenden. De viktigaste beslutens huvudsakliga innehåll var:UtdelningStämman beslutade att utdelning inte lämnas för räkenskapsåret 2019/20 och att till årsstämmans förfogande stående medel om 1 705 759 197 kronor balanseras i ny räkning.StyrelseStämman godkände omval av Carina Andersson, Gerald Engström, Patrik Nolåker, Svein Nilsen och Gunilla Spongh. Gerald Engström valdes till ordförande i styrelsen.ValberedningStyrelsens ordförande gavs i uppdrag att kontakta de tre röstmässigt största aktieägarna...

Continue reading

2020 nr. 09 – Delårsrapport for 1. halvår 2020

Aalborg, 27. august 2020Kontaktperson:                                                                                                                                Adm. direktør                                                                                                                                Christian B. Lund                                                                                                                Tlf. 96 30 60 00e-mail: cbl@sanistaal.dkFornuftigt resultat i et COVID-19 ramt 2. kvartal – Forventningerne til året præciseresDriftsindtjeningen (EBITDA) for 2. kvartal 2020 blev stort set på niveau med samme periode året før, selv om COVID-19 krisen især i april og maj påvirkede kunde- og produktmikset negativt.Hovedpunkter i 2. kvartal 2020Sammenligningstal for 2. kvartal 2019 og 1. halvår 2019 er justeret...

Continue reading

Hydroxychloroquine Market to Reach $2,339.1 Million by 2027; Increasing Demand for the Product Will provide Impetus to Market Growth, says Fortune Business Insights™

Pune, Aug. 27, 2020 (GLOBE NEWSWIRE) — The global hydroxychloroquine market size is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years. According to a report published by Fortune Business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027,” the market was worth USD 894.0 million in 2019 and will exhibit a CAGR of 5.5% during the forecast period, 2020-2027.The report on the hydroxychloroquine market highlights:Reliable insights on the latest developmentsObtained data with grander analysisKey market drivers and trendsComprehensive...

Continue reading

Arrow Exploration Announces Second Quarter 2020 Financial and Operating Results

CALGARY, Alberta, Aug. 27, 2020 (GLOBE NEWSWIRE) — ARROW Exploration Corp. (“Arrow” or the “Company”) (TSXV: AXL) is pleased to announce the filing of its unaudited Financial Statements and MD&A for the quarter-ended June 30th, 2020, which are available on SEDAR (www.sedar.com).FINANCIAL AND OPERATING HIGHLIGHTS(1)Non-IFRS measures – see “Non-IFRS Measures” section within the MD&A(2)Long term restricted cash not included in working capitalMarshall Abbott, CEO of Arrow commented, “The second quarter of 2020 saw the continuation of significant challenges for the international oil & gas industry, following the outbreak of the COVID-19 pandemic in the first quarter. Arrow continued to face many of these same challenges in the second quarter, including lower crude oil prices as a result of reduced global oil demand.”Mr....

Continue reading

FOMO CORP. Agrees to Buy Purge Virus

Chicago, IL, Aug. 27, 2020 (GLOBE NEWSWIRE) — FOMO CORP. (US OTC: ETFM) is pleased to announce that it has signed a letter of intent (LOI) to acquire Purge Virus (www.purgevirus.com), a provider of COVID-19 disinfection technology, supplies and Personal Protective Equipment (PPE) products/services.Purge Virus brings many benefits to ETFM including:A total solutions package to allow enterprises to disinfect their premises from COVID-19 and future infectious diseases the world may encounter, which is estimated to be a multi-billion-dollar market opportunity;Ultraviolet lighting solutions, bipolar ionization, and photoplasma, plus PPE products/sales to assist clients in protecting their premises and clients from virus proliferation, which is an urgent global need;A vibrant existing business which will generate significant revenues and...

Continue reading

Park Street Nordicom A/S – Interim Financial Report, 1st half of 2020

Park Street Nordicom A/S – Interim Financial report, 1st half of 2020Copenhagen, 27 August 2020In the first half of 2020 Park Street Nordicom achieved EBVAT (Earnings before value adjustments and tax) of DKK 36.2 million (2019: DKK 40.4 million). Profit for the period after tax is DKK 63.3 million against DKK 36.5 million in 2019. The increase compared to previous year is due to the profit generated in the sale of two properties (DKK 38.3 million).The Group Equity at 30 of June 2020 is DKK 994.5 million compared to DKK 931.1 million at 31 December 2019; with the increase attributed to the profit of the period. The Group has also repaid a loan facility existing at 31 December 2019 with a total value of DKK 105.1 million.The Board of Directors of Park Street Nordicom A/S today discussed and approved the company’s Interim report 2020,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.